We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$36.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.53B
Cap. Flow %
6.98%
Top 10 Hldgs %
34.28%
Holding
1,878
New
44
Increased
1,328
Reduced
301
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$448M
2
TSLA icon
Tesla
TSLA
+$327M
3
BAC icon
Bank of America
BAC
+$242M
4
NFLX icon
Netflix
NFLX
+$228M
5
IBM icon
IBM
IBM
+$178M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$305M
2
AMZN icon
Amazon
AMZN
+$251M
3
META icon
Meta Platforms (Facebook)
META
+$251M
4
ACN icon
Accenture
ACN
+$169M
5
APP icon
Applovin
APP
+$138M

Sector Composition

Rank Sector Weight
1 Technology 34.29%
2 Healthcare 13.65%
3 Financials 13.36%
4 Consumer Discretionary 10.64%
5 Communication Services 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTGT icon
1751
TechTarget
TTGT
$317M
$43K ﹤0.01%
2,178
+962
+79% +$25.4K
INVX
1752
Innovex International
INVX
$2.13B
$43K ﹤0.01%
3,098
– –
GEAR
1753
DELISTED
Revelyst, Inc.
GEAR
$43K ﹤0.01%
+2,252
New +$42.9K
WOLF icon
1754
Wolfspeed
WOLF
$1.31B
$40K ﹤0.01%
6,064
+2,629
+77% +$26.8K
DNTH icon
1755
Dianthus Therapeutics
DNTH
$6.29B
$35K ﹤0.01%
+1,593
New +$41K
DNA icon
1756
Ginkgo Bioworks
DNA
$612M
$31K ﹤0.01%
+3,113
New +$26.7K
KROS icon
1757
Keros Therapeutics
KROS
$198M
$26K ﹤0.01%
1,622
+359
+28% +$18.7K
OLMA icon
1758
Olema Pharmaceuticals
OLMA
$1.01B
$24K ﹤0.01%
+4,075
New +$40.7K
GRAL
1759
GRAIL Inc
GRAL
$3.18B
$8K ﹤0.01%
497
-1,088
-69% -$17.7K
FLNA
1760
Filana Therapeutics
FLNA
$46.4M
$5K ﹤0.01%
1,944
– –
NLOP
1761
Net Lease Office Properties
NLOP
$176M
$3K ﹤0.01%
106
– –
AGL icon
1762
Agilon Health
AGL
$1.8B
– –
-385
Closed -$38K
ASPN icon
1763
Aspen Aerogels
ASPN
$415M
– –
-1,764
Closed -$49K
ATHM icon
1764
Autohome
ATHM
$2.65B
– –
-8,032
Closed -$262K
DCH
1765
Dauch Corp
DCH
$1.42B
– –
-7,160
Closed -$44K
BLMN icon
1766
Bloomin' Brands
BLMN
$1.01B
– –
-3,371
Closed -$56K
CAL icon
1767
Caleres
CAL
$481M
– –
-1,440
Closed -$48K
CHPT icon
1768
ChargePoint
CHPT
$150M
– –
-4,424
Closed -$121K
CLLS
1769
Cellectis
CLLS
$279M
– –
-163,447
Closed -$347K
CVI icon
1770
CVR Energy
CVI
$3.14B
– –
-1,593
Closed -$37K
EYE icon
1771
National Vision
EYE
$1.85B
– –
-3,291
Closed -$36K
GLOB icon
1772
Globant
GLOB
$1.66B
– –
-535
Closed -$106K
HFWA icon
1773
Heritage Financial
HFWA
$1.23B
– –
-1,884
Closed -$41K
HRTX icon
1774
Heron Therapeutics
HRTX
$95.5M
– –
-289,269
Closed -$576K
HSTM icon
1775
HealthStream
HSTM
$818M
– –
-1,285
Closed -$37K
69 70
71
72 73

Similar funds

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

KBC Group's Q4 2024 Portfolio in Review

As of Q4 2024, KBC Group held 1,878 positions worth $36.3B, up 9.7% from $33.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

KBC Group deployed $2.53B of net new capital in Q4 2024, opening 44 new positions and adding to 1,328 existing holdings. Its largest new stake was Primo Brands: 1,611,484 shares worth $49.6M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Procter & Gamble, an estimated $305M trimmed.

  • KBC Group's largest Q4 2024 buy was Primo Brands: 1,611,484 shares worth $49.6M.
  • KBC Group added most to Apple in Q4 2024, an estimated $448M increase.
  • KBC Group's biggest Q4 2024 reduction was Procter & Gamble, cutting an estimated $305M.
  • KBC Group fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $4.35M.
  • KBC Group's ten largest holdings make up 34% of its $36.3B portfolio in Q4 2024.
  • KBC Group opened 44 new positions and closed 46 in Q4 2024.
  • KBC Group's portfolio value rose 9.7% quarter-over-quarter to $36.3B.

Based on KBC Group's 13F filing for Q4 2024, filed 22 Jan 2025.